Shorla Oncology Is A Specialty Pharmaceutical Company Based In The U Sand Irelanddedicated To Developing And Commercializing Innovative Oncology Treatmentsthe Company Focuses On Underserved Patient Populationsincluding Women And Childrenby Reformulating Existing Therapies To Enhance Accessibilityaffordabilityand Clinical Outcomesfounded As Shorla Pharma And Rebranded In 2022Shorla Targets Oncology Indications With Limited Treatment Options The Company Specializes In Drug Developmentparticularly In Reformulating Oncology Drugs To Improve Dosing Precision And Patient Convenienceits Flagship Productimkeldiis The First Oral Liquid Formulation Of Imatinibdesigned For Precise Dosing In Leukemia And Other Cancersshorla Has Established A Dedicated U Ssales Force And Market Access Teams To Ensure The Availability Of Its Productscollaborating With Healthcare Providers And Patients To Address Unmet Needs In Oncology Treatmentled By Ceo Sharon Cunningham And Cco Rayna Hermanshorla Is Committed To Improving Patient Care Through Formulation Innovation And Real World Clinical Insights
